Moderna (NASDAQ:MRNA) presented Phase 3 results for intismeran, its individualized neoantigen therapy, in combination with ...
Flu activity in the US is climbing earlier than usual, with the West Coast already seeing the highest levels by early October and the A(H1)pdm09 strain dominating national cases. Scientists are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results